UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Jennison Associates LLC

Jennison Associates LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 240,783 shares of the healthcare conglomerate’s stock after buying an additional 277 shares during the quarter. Jennison Associates LLC’s holdings in UnitedHealth Group were worth $140,781,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. China Universal Asset Management Co. Ltd. lifted its stake in UnitedHealth Group by 20.6% during the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after purchasing an additional 1,857 shares during the last quarter. Quent Capital LLC raised its position in shares of UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after purchasing an additional 217 shares during the period. EntryPoint Capital LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $75,000. EP Wealth Advisors LLC raised its holdings in UnitedHealth Group by 79.4% during the 1st quarter. EP Wealth Advisors LLC now owns 79,538 shares of the healthcare conglomerate’s stock worth $39,347,000 after buying an additional 35,198 shares during the period. Finally, Advisors Asset Management Inc. increased its position in shares of UnitedHealth Group by 12.2% in the first quarter. Advisors Asset Management Inc. now owns 41,746 shares of the healthcare conglomerate’s stock worth $20,652,000 after acquiring an additional 4,538 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on UNH shares. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Down 2.2 %

UNH stock opened at $576.93 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a market capitalization of $530.94 billion, a price-to-earnings ratio of 37.59, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The company has a 50-day moving average of $582.31 and a two-hundred day moving average of $551.25.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.